The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
Year: 2024
Type: article
Study design: Observational Study
Authors: Hepner, Adriana; https://orcid.org/0000-0002-8716-9401, Versluis, Judith M, Wallace, Roslyn, Allayous, Clara; https://orcid.org/0000-0002-1762-152X, Brown, Lauren Julia; https://orcid.org/0000-0002-9340-8392, Trojaniello, Claudia, Gerard, Camille Lea; https://orcid.org/0000-0002-6007-1746, Jansen, Yanina JL, Bhave, Prachi; https://orcid.org/0000-0001-9084-8467, Neyns, Bart; https://orcid.org/0000-0003-0658-5903, Haydon, Andrew; https://orcid.org/0000-0002-4631-5855, Michielin, Olivier, Mangana, Joanna, Klein, Oliver; https://orcid.org/0000-0003-0022-9553, Shoushtari, Alexander N, Warner, Allison Betof, Ascierto, Paolo Antonio; https://orcid.org/0000-0002-8322-475X, McQuade, Jennifer Leigh, Carlino, Matteo S, Zimmer, Lisa; https://orcid.org/0000-0002-3680-3521, Lebbe, Celeste, Johnson, Douglas B, Sandhu, Shahneen, Atkinson, Victoria; https://orcid.org/0000-0002-9806-9019, Blank, Christian U, Lo, Serigne N, Long, Georgina V, Menzies, Alexander M
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7212014779